206. Fragile X syndrome Clinical trials / Disease details
Clinical trials : 104 / Drugs : 87 - (DrugBank : 32) / Drug target genes : 54 - Drug target pathways : 79
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01474746 (ClinicalTrials.gov) | January 2012 | 10/11/2011 | Trial of Sertraline to Treat Children With Fragile X Syndrome | A Controlled Trial of Sertraline in Young Children With Fragile X Syndrome | Fragile X Syndrome | Drug: Sertraline;Drug: Placebo | Randi J. Hagerman, MD | NULL | Completed | 24 Months | 68 Months | All | 57 | Phase 2 | United States |